Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong
· Delayed Price · Currency is HKD 1.500
+0.030 (2.04%)
Mar 10, 2026, 11:59 AM HKT
HKG:0460 Revenue
Sihuan Pharmaceutical Holdings Group had revenue of 1.15B CNY in the half year ending June 30, 2025, with 8.57% growth. This brings the company's revenue in the last twelve months to 2.10B, up 19.55% year-over-year. In the year 2024, Sihuan Pharmaceutical Holdings Group had annual revenue of 1.90B with 2.18% growth.
Revenue (ttm)
2.10B CNY
Revenue Growth
+19.55%
P/S Ratio
5.81
Revenue / Employee
758.08K CNY
Employees
2,767
Market Cap
13.35B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
| Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
| Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
| Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
| Dec 31, 2020 | 2.46B | -414.09M | -14.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Consun Pharmaceutical Group | 3.58B |
| CanSino Biologics | 1.19B |
| CF PharmTech | 647.51M |
| Luye Pharma Group | 6.76B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |